Faron Pharmaceuticals Oy (FARN.L)
GBp 175.0
(2.94%)
GBp 175.0
(2.94%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 10.22 Million EUR | -9.32% |
| 2022 | 11.27 Million EUR | -14.5% |
| 2021 | 13.18 Million EUR | 57.55% |
| 2020 | 8.36 Million EUR | -18.04% |
| 2019 | 10.2 Million EUR | 27.58% |
| 2018 | 8 Million EUR | -46.25% |
| 2017 | 14.88 Million EUR | -13.88% |
| 2016 | 17.28 Million EUR | 16.64% |
| 2015 | 14.82 Million EUR | 584.57% |
| 2014 | 2.16 Million EUR | -3.22% |
| 2013 | 2.23 Million EUR | 15.55% |
| 2012 | 1.93 Million EUR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 35.46 Million EUR | 246.97% |
| 2024 Q2 | 35.46 Million EUR | 0.0% |
| 2023 Q2 | 12.83 Million EUR | 0.0% |
| 2023 Q1 | 12.83 Million EUR | 13.89% |
| 2023 Q3 | 10.22 Million EUR | -20.38% |
| 2023 Q4 | 10.22 Million EUR | 0.0% |
| 2023 FY | 10.22 Million EUR | -9.32% |
| 2022 Q1 | 16.72 Million EUR | 26.91% |
| 2022 Q3 | 11.27 Million EUR | -32.63% |
| 2022 FY | 11.27 Million EUR | -14.5% |
| 2022 Q4 | 11.27 Million EUR | 0.0% |
| 2022 Q2 | 16.72 Million EUR | 0.0% |
| 2021 Q3 | 13.18 Million EUR | 11.1% |
| 2021 Q2 | 11.86 Million EUR | 0.0% |
| 2021 Q1 | 11.86 Million EUR | 41.81% |
| 2021 FY | 13.18 Million EUR | 57.55% |
| 2021 Q4 | 13.18 Million EUR | 0.0% |
| 2020 Q3 | 8.36 Million EUR | -41.66% |
| 2020 FY | 8.36 Million EUR | -18.04% |
| 2020 Q4 | 8.36 Million EUR | 0.0% |
| 2020 Q2 | 14.34 Million EUR | 0.0% |
| 2020 Q1 | 14.34 Million EUR | 40.49% |
| 2019 Q4 | 10.2 Million EUR | 0.0% |
| 2019 FY | 10.2 Million EUR | 27.58% |
| 2019 Q1 | 5.1 Million EUR | -36.23% |
| 2019 Q2 | 5.1 Million EUR | 0.0% |
| 2019 Q3 | 10.2 Million EUR | 100.06% |
| 2018 FY | 8 Million EUR | -46.25% |
| 2018 Q3 | 8 Million EUR | -52.14% |
| 2018 Q1 | 16.72 Million EUR | 12.32% |
| 2018 Q2 | 16.72 Million EUR | 0.0% |
| 2018 Q4 | 8 Million EUR | 0.0% |
| 2017 Q1 | 16.08 Million EUR | -6.96% |
| 2017 Q4 | 14.88 Million EUR | 0.0% |
| 2017 Q3 | 14.88 Million EUR | -7.44% |
| 2017 Q2 | 16.08 Million EUR | 0.0% |
| 2017 FY | 14.88 Million EUR | -13.88% |
| 2016 Q3 | 15.74 Million EUR | 7.35% |
| 2016 FY | 17.28 Million EUR | 16.64% |
| 2016 Q1 | 14.66 Million EUR | -1.03% |
| 2016 Q2 | 14.66 Million EUR | 0.0% |
| 2016 Q4 | 17.28 Million EUR | 9.78% |
| 2015 Q2 | 4.75 Million EUR | 0.0% |
| 2015 Q4 | 14.82 Million EUR | 0.0% |
| 2015 Q3 | 14.82 Million EUR | 211.89% |
| 2015 Q1 | 4.75 Million EUR | 119.49% |
| 2015 FY | 14.82 Million EUR | 584.57% |
| 2014 FY | 2.16 Million EUR | -3.22% |
| 2014 Q1 | - EUR | 0.0% |
| 2014 Q3 | 2.16 Million EUR | 0.0% |
| 2014 Q4 | 2.16 Million EUR | 0.0% |
| 2013 FY | 2.23 Million EUR | 15.55% |
| 2012 FY | 1.93 Million EUR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|